Adam Travis, MD
Vice President, Corporate Development

Adam Travis is Vice President of Corporate Development at Raven. Adam’s primary responsibility is supporting new venture incubation in healthcare tech / software and tech-enabled services. Prior to Raven, Adam was VP Corporate Strategy at Teladoc Health, a scale-leading international provider of virtual and digital healthcare products and services. In this role, Adam was responsible for leading long-range strategic and financial planning, enterprise product and platform investment planning, and growth / GTM strategy for Teladoc’s largest business unit focused on services sold to US payers and self-insured employers. Adam began his career as a radiologist, but for the past 10+ years he has worked entirely in Strategy, GM, and Product leadership roles in health tech and healthcare delivery businesses and has advised clients and led Product and Commercial teams as an expert on care delivery innovation and value-based care. Prior to joining Teladoc through its acquisition of Livongo in 2020, Adam was a VP of Product Management and GM at Clarify Health and before that a Principal at Boston Consulting Group where he focused on growth and M&A strategy for clients spanning biopharma, medical device, payer, and provider sectors of the healthcare industry. Adam completed residency training and board certification in diagnostic radiology at University of Chicago Hospitals where he served as Chief Resident in 2012. Adam holds an MD from University of Louisville School of Medicine and a BE in Biomedical Engineering with Honors from Vanderbilt University.
Department
Raven
Degree
MD
Joined
2024
University / College
Vanderbilt University, University of Louisville School of Medicine
Adam Travis